Halozyme Therapeutics shares owned by Qube Research & Technologies
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Qube Research & Technologies
from 13F filings
Historical chart of Qube Research & Technologies investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Qube Research & Technologies
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $2.1M | 41k | 52.36 |
| 2024-03-31 | $15M | 363k | 40.68 |
| 2023-09-30 | $985k | 26k | 38.20 |
| 2023-06-30 | $5.0M | 138k | 36.07 |
| 2023-03-31 | $727k | 19k | 38.19 |
| 2022-12-31 | $6.0M | 105k | 56.90 |
| 2022-06-30 | $2.3M | 53k | 43.99 |
| 2021-09-30 | $413k | 10k | 40.68 |
| 2021-06-30 | $987k | 22k | 45.42 |
| 2021-03-31 | $2.1M | 50k | 41.70 |
| 2020-12-31 | $2.6M | 62k | 42.70 |
| 2020-09-30 | $323k | 12k | 26.32 |
| 2020-06-30 | $459k | 17k | 26.82 |
| 2019-12-31 | $1.3M | 74k | 17.73 |
More positions owned by Qube Research & Technologies
View all positions for Qube Research & Technologies